Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: Two cases of after solid organ transplantation
- 1 January 1989
- journal article
- case report
- Published by Elsevier in The American Journal of Medicine
- Vol. 86 (2) , 241-244
- https://doi.org/10.1016/0002-9343(89)90279-9
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Treatment of Severe Epstein-Barr Virus-Induced Polyclonal B-Lymphocyte Proliferation by Anti-B-Cell Monoclonal AntibodiesAnnals of Internal Medicine, 1988
- Synthesis and antiherpes simplex virus activity of 9-[(1,3-dihydroxy-2-propylthio)methyl]guanineJournal of Medicinal Chemistry, 1985
- LYMPHOPROLIFERATIVE DISORDERS IN CARDIAC TRANSPLANT RECIPIENTS ARE MULTICLONAL LYMPHOMASThe Lancet, 1984
- REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPYThe Lancet, 1984
- Monoclonality of Lymphoproliferative Lesions in Cardiac-Transplant RecipientsNew England Journal of Medicine, 1984
- Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitroAntimicrobial Agents and Chemotherapy, 1983
- Epstein-Barr Virus (EBV) Induced Polyclonal and Monoclonal B-Cell Lymphoproliferative Diseases Occurring after Renal TransplantationAnnals of Surgery, 1983
- 9-(1,3-Dihydroxy-2-propoxymethyl)guanine: a new potent and selective antiherpes agentJournal of Medicinal Chemistry, 1983
- Treatment of life-threatening Epstein-Barr virus infections with acyclovirThe American Journal of Medicine, 1982
- Epstein–Barr Virus-Induced B-Cell Lymphoma after Renal TransplantationNew England Journal of Medicine, 1982